# A Study to Evaluate the Metabolism and Excretion of BMS-986369 in Healthy Male Participants

> **NCT05567510** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 8 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986369

## Key facts

- **NCT ID:** NCT05567510
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-20
- **Primary completion:** 2022-12-27
- **Final completion:** 2022-12-27
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05567510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05567510, "A Study to Evaluate the Metabolism and Excretion of BMS-986369 in Healthy Male Participants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05567510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*